Rhinoscope devices market seen reaching $7.04 billion by 2030

The rhinoscope devices market is projected to grow from $5.05 billion in 2025 to $7.04 billion by 2030, driven by rising ENT disorders, more sinus infections and demand for portable imaging tools. North America led the market in 2025, while the report points to stronger outpatient diagnostics and high-definition video rhinoscopy ahead.

Why it matters: - Rhinoscope devices are a core diagnostic tool for nasal and sinus conditions, so growth in this market tracks broader demand for ENT care and earlier diagnosis. - The market’s rise signals more spending on outpatient diagnostics, portable equipment and improved visualization tools.

What happened: - The rhinoscope devices market reached $5.05 billion in 2025. - The market is expected to rise to $5.41 billion in 2026. - The market is projected to reach $7.04 billion by 2030. - The Business Research Company published the market research on Aug. 28, 2026. - The report said North America was the largest regional market in 2025.

The details: - Rhinoscope devices are medical tools used to examine the nasal passages and sinus cavities. - The devices help diagnose nasal blockages, infections, structural abnormalities and other nasal disorders. - The 2025 to 2026 growth forecast implies a 7.0% compound annual growth rate. - The 2026 to 2030 forecast implies a 6.8% compound annual growth rate. - The report links near-term growth to more ENT disorders, higher demand for hospital-based diagnostic procedures, advances in optical imaging, growth in ENT specialty care and more sinus infection cases. - The longer-term outlook reflects a shift toward outpatient diagnostics, demand for compact and portable imaging equipment, an aging population, better visualization tools and greater awareness of ENT screening. - Key trends highlighted in the report include high-definition video rhinoscopy, minimally invasive diagnostic approaches, portable rhinoscope devices and improved optical fiber materials. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa in addition to North America. - The Business Research Company offers a free sample of the report here. - The full report is available here.

Between the lines: - Rising nasal disorder prevalence is the main growth catalyst in the report. - Environmental allergens such as pollen and dust mites are contributing to more nasal conditions. - Older adults are more vulnerable to chronic sinusitis and nasal polyps. - The report cites World Health Organization data from September 2023 on the global burden of chronic disease. - The report also cites American Academy of Otolaryngology–Head and Neck Surgery data from May 2023 showing allergic rhinitis affects 5% to 50% of the global population. - That prevalence helps explain why nasal diagnostics remain a steady clinical need, even outside hospital settings.

What's next: - The market is likely to benefit from broader adoption of portable and high-definition rhinoscopy systems. - Continued product development in visualization and optical materials should support the shift toward outpatient care. - The report’s regional breakdown suggests growth opportunities remain broad, not limited to North America.

The bottom line: - Rhinoscope devices are moving from a niche diagnostic category into a growth market tied to rising ENT demand, better imaging and more outpatient care.